{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:06:21Z","timestamp":1758056781368,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.encep.2014.12.003","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T11:49:11Z","timestamp":1422359351000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Niveau de vigilance des psychiatres pour les facteurs de risque cardiovasculaire chez les patients schizophr\u00e8nes"],"prefix":"10.1016","volume":"41","author":[{"given":"F.","family":"Rouillon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Van Ganse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vekhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Depret-Bixio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dillenschneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.encep.2014.12.003_bib0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amp.2009.05.003","article-title":"Mortalit\u00e9 et surmortalit\u00e9 dans la schizophr\u00e9nie","volume":"167","author":"Loas","year":"2009","journal-title":"Ann Med Psychol (Paris)"},{"issue":"5.","key":"10.1016\/j.encep.2014.12.003_bib0010","article-title":"Mortality in schizophrenia and related psychoses: data from two cohorts, 1875\u20131924\u00a0and 1994\u20132010","volume":"2","author":"Healy","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.encep.2014.12.003_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/YCO.0b013e32835035ca","article-title":"Life expectancy and cardiovascular mortality in persons with schizophrenia","volume":"25","author":"Laursen","year":"2012","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2014.12.003_bib0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2013.02.025","article-title":"Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades \u2014 A Danish nationwide study from 1980\u00a0to 2010","volume":"146","author":"Nielsen","year":"2013","journal-title":"Schizophr Res"},{"issue":"6","key":"10.1016\/j.encep.2014.12.003_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","article-title":"Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)","volume":"24","author":"De Hert","year":"2009","journal-title":"Eur Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2014.12.003_bib0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2515\/therapie:2008029","article-title":"L\u2019enjeu de la mortalit\u00e9 dans la schizophr\u00e9nie","volume":"63","author":"Corruble","year":"2008","journal-title":"Therapie"},{"key":"10.1016\/j.encep.2014.12.003_bib0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.encep.2007.07.005","article-title":"Mortalit\u00e9 et causes de d\u00e9c\u00e8s dans la schizophr\u00e9nie\u00a0: \u00e9tude prospective entre dix et 14ans d\u2019une cohorte de 150\u00a0sujets","volume":"34","author":"Loas","year":"2008","journal-title":"Enc\u00e9phale"},{"issue":"2","key":"10.1016\/j.encep.2014.12.003_bib0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.encep.2008.02.009","article-title":"Approche clinique du suicide au cours de la schizophr\u00e9nie (I). Identification des facteurs de risque","volume":"35","author":"Besnier","year":"2009","journal-title":"Enc\u00e9phale"},{"issue":"3","key":"10.1016\/j.encep.2014.12.003_bib0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.euroneuro.2005.09.003","article-title":"Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment","volume":"16","author":"Cohen","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2014.12.003_bib0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders \u2014 A systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.encep.2014.12.003_bib0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-244X-11-173","article-title":"Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3\u00a0months of treatment with antipsychotics \u2013\u00a0results from a German observational study","volume":"11","author":"Kraemer","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2014.12.003_bib0060","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/jama.298.15.1794","article-title":"Severe mental illness and risk of cardiovascular disease","volume":"298","author":"Newcomer","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.encep.2014.12.003_bib0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4088\/JCP.v66n0205","article-title":"Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists","volume":"66","author":"Goff","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.encep.2014.12.003_bib0070","doi-asserted-by":"crossref","first-page":"e68717","DOI":"10.1371\/journal.pone.0068717","article-title":"Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics","volume":"8","author":"McEvoy","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.encep.2014.12.003_bib0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","author":"American Diabetes Association (ADA)","year":"2004","journal-title":"Diabetes Care"},{"issue":"Suppl.\u00a018","key":"10.1016\/j.encep.2014.12.003_bib0080","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study","volume":"65","author":"McQuade","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.encep.2014.12.003_bib0085","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.encep.2014.12.003_bib0090","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.161.8.1334","article-title":"Physical health monitoring of patients with schizophrenia","volume":"161","author":"Marder","year":"2004","journal-title":"Am J Psychiatry"},{"year":"2007","series-title":"Guide ALD 23 \u00ab\u00a0Schizophr\u00e9nies\u00a0\u00bb. Guide \u2013 Affection de longue dur\u00e9e","author":"HAS","key":"10.1016\/j.encep.2014.12.003_bib0095"},{"issue":"2","key":"10.1016\/j.encep.2014.12.003_bib0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.schres.2005.04.010","article-title":"Clinicians\u2019 recognition of the metabolic adverse effects of antipsychotic medications","volume":"79","author":"Buckley","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2014.12.003_bib0105","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1185\/030079906X148616","article-title":"Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005\u00a0survey of physicians in clinical practice","volume":"22","author":"Ketter","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.encep.2014.12.003_bib0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.schres.2008.04.040","article-title":"Assessment of physical activity in middle-aged and older adults with schizophrenia","volume":"104","author":"Lindamer","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2014.12.003_bib0115","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1037\/0021-843X.111.4.687","article-title":"Nicotine and familial vulnerability to schizophrenia: a discordant twin study","volume":"111","author":"Lyons","year":"2002","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.encep.2014.12.003_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ps.201200143","article-title":"Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999\u20132011","volume":"64","author":"Dickerson","year":"2013","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.encep.2014.12.003_bib0125","first-page":"143","article-title":"Tabagisme et schizophr\u00e9nie\u00a0: impacts sur la maladie et son traitement","volume":"6","author":"L\u00e9gar\u00e9","year":"2007","journal-title":"Drog Sante Soc"},{"key":"10.1016\/j.encep.2014.12.003_bib0130","first-page":"8","article-title":"Pour une approche pluridisciplinaire des soins somatiques en psychiatrie","volume":"238","author":"Saravane","year":"2005","journal-title":"Soins Psychiatr"},{"key":"10.1016\/j.encep.2014.12.003_bib0135","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4088\/JCP.v69n0219","article-title":"Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data","volume":"69","author":"Morrato","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.encep.2014.12.003_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2006.06.026","article-title":"Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline","volume":"86","author":"Nasrallah","year":"2006","journal-title":"Schizophr Res"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370061400284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370061400284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:35:50Z","timestamp":1757957750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001370061400284X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S001370061400284X"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2014.12.003","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niveau de vigilance des psychiatres pour les facteurs de risque cardiovasculaire chez les patients schizophr\u00e8nes","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2014.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}